4.7 Article

Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biology

Sarcopenia-The Impact on Physical Capacity of Liver Transplant Patients

Maciej Miarka et al.

Summary: Sarcopenia is common in liver transplant recipients and is associated with lower BMI, lower peak oxygen uptake, and higher NTproBNP levels. It is also correlated with poorer cardio-pulmonary performance before LT and prolonged ICU stay after grafting.

LIFE-BASEL (2021)

Review Medicine, General & Internal

Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic Outcomes

Laura I. Coman et al.

Summary: Research indicates that patients with diabetes mellitus and liver cirrhosis are at higher risk for complications such as hepatic encephalopathy, variceal hemorrhage, infections, and hepatocellular carcinoma. Diabetes mellitus also negatively impacts liver transplant outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Oncology

Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma

Israa T. Ismail et al.

Summary: Hepatocellular carcinoma (HCC) has a poor prognosis and is a leading cause of mortality worldwide. This study analyzed lipid alterations in blood and tissues of HCC patients compared to healthy controls and those with chronic liver disease. The research identified significant changes in lipid composition, particularly in triacylglycerides and phosphatidylcholines, between healthy controls, CLD patients, and HCC patients. These findings may have implications for the prevention, early detection, and treatment of HCC.

CANCERS (2021)

Review Medicine, General & Internal

Acute-on-Chronic Liver Failure in Cirrhosis

Carmine Gambino et al.

Summary: ACLF is a syndrome that develops in patients with acutely decompensated chronic liver disease, characterized by high mortality, organ failures, and systemic inflammation. Different scientific societies have proposed diagnostic criteria and clinical characteristics for ACLF, along with established and experimental treatments. Further research is needed to better understand the pathophysiology of the syndrome and explore new therapies.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Medicine, General & Internal

Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review

Liliana Lykowska-Szuber et al.

Summary: COVID-19 affects various organs beyond the respiratory system, with common comorbidities including hypertension, diabetes, cardiovascular and respiratory diseases; Obesity and chronic diseases are associated with increased susceptibility to SARS-CoV2 infection; Liver disease in patients with pre-existing conditions may require special attention in the event of COVID-19 infection.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Micro-Elimination: Updated Pathway to Global Elimination of Hepatitis C in Small Communities and Industrial Settings during the COVID 19 Pandemic

Anca Elena Butaru et al.

Summary: Romania is striving for national elimination of hepatitis C virus infections by expanding successful micro-elimination projects to test and treat specific populations and at-risk groups. Research found that individuals with HCV infection in disadvantaged regions lack proper medical care access.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Medicine, General & Internal

Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine

Dimitrios A. Vrachatis et al.

Summary: The article discusses the epidemiology and clinical features of COVID-19, analyzing the importance of immune dysregulation and hypercoagulability in disease complications, and provides an up-to-date systematic review of colchicine's immunomodulating capacity in hindering coronavirus complications.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Cell Biology

Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease

Stanislav Kotlyarov et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) and chronic obstructive pulmonary disease (COPD) share common pathogenic mechanisms, including impaired lipid metabolism, but many aspects remain controversial.
Review Biology

Sarcopenia and Frailty in Liver Cirrhosis

Hiroki Nishikawa et al.

Summary: Skeletal muscle atrophy is caused by a shift in the balance of protein synthesis and degradation, while primary and secondary sarcopenia have different definitions and impact skeletal muscle mass and strength. Patients with liver cirrhosis experience increasing muscle mass loss as liver reserve worsens, and frailty and sarcopenia can be adverse predictors for cirrhotic patients.

LIFE-BASEL (2021)

Review Biochemistry & Molecular Biology

Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors

Yoshihisa Takahashi et al.

Summary: Immunohistochemistry plays a vital role in the pathological diagnosis of liver tumors, helping to determine specific types and subtypes of tumors. Immunohistochemical markers include those of hepatocellular differentiation and malignant hepatocytes, which are crucial for differential diagnosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Virology

Liver injury in COVID-19: clinical features and treatment management

Dongdong Yu et al.

Summary: This article discusses the latest developments in the pathogenesis of liver injury caused by SARS-CoV-2, as well as the prone population and clinical characteristics of these patients, providing suggestions for clinical treatment.

VIROLOGY JOURNAL (2021)

Review Nutrition & Dietetics

Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases

Joao V. S. Guerra et al.

Summary: The incidence of NCDs is increasing globally, with changes in dietary and physical activity patterns, as well as genetic factors, being main contributors. Understanding the molecular mechanisms of these diseases can help in developing more effective treatments. NCDs play a crucial role globally and have an impact on the progression and severity of COVID-19.

NUTRIENTS (2021)

Article Medicine, General & Internal

Predictive Value of Comorbid Conditions for COVID-19 Mortality

Iosif Marincu et al.

Summary: This study developed a predictive model for the survival rate of COVID-19 patients using a Bayesian approach, assessing mortality risk based on disease groups, gender, and age, providing a risk assessment tool for medical workers, and can be generalized for hospital use.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Cell Biology

Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis

Beatrice Foglia et al.

Summary: Liver fibrosis is a potentially reversible pathophysiological event characterized by excess deposition of extracellular matrix components, which is primarily driven by activated myofibroblasts and other hepatic cell populations involved in chronic liver disease progression. The emerging pathogenic role of hypoxia, hypoxia-inducible factors, and related mediators in the fibrogenic progression of chronic liver diseases is a key focus of research.
Review Medicine, Research & Experimental

Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis

Donovan A. McGrowder et al.

Summary: Liver injury is common in COVID-19 patients, with potential pathogenic mechanisms including drug-induced liver injury, SARS-CoV-2 infection, and systemic inflammatory response. Liver biochemistry tests serve as prognostic markers and should be carefully monitored.

DISEASES (2021)

Article Medicine, General & Internal

Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic

Bianca Cerbu et al.

Summary: This study found that active HCV infection is an independent risk factor for all-cause mortality in COVID-19 patients. There was a significantly higher proportion of severe COVID-19 cases in the active HCV group compared to the non-active HCV group.

MEDICINA-LITHUANIA (2021)

Review Infectious Diseases

Elimination of hepatitis C in Europe: can WHO targets be achieved?

M. Maticic et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Review Medicine, General & Internal

COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature

Michal Kukla et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Microbiology

SARS-CoV-2 Infection and the Liver

Katie Morgan et al.

PATHOGENS (2020)

Article Medicine, General & Internal

Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study

Pierpaolo Di Micco et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Medicine, General & Internal

The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease

Katrine D. Galsgaard

JOURNAL OF CLINICAL MEDICINE (2020)

Article Medicine, General & Internal

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension

Abdurrahman Sahin et al.

JOURNAL OF CLINICAL MEDICINE (2018)

Review Gastroenterology & Hepatology

Epidemiology of hepatitis C in Europe

Francesco Negro

DIGESTIVE AND LIVER DISEASE (2014)

Review Gastroenterology & Hepatology

Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management

Diego Garcia-Compean et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)